E Fund Management Co., Ltd. Alector, Inc. Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$5.69 - $8.08 $16,119 - $22,890	2,833 Added 27.8%	13,025 $78,000
Q4 2023 Feb 06, 2024	BUY	$3.77 - $8.39 $38,423 - $85,510	10,192 New	10,192 $81,000
Q1 2023 May 11, 2023	BUY	$5.85 - $9.84 $18,708 - $31,468	3,198 Added 29.36%	14,089 $87,000
Q4 2022 Feb 14, 2023	SELL	$6.88 - $9.55 $13,588 - $18,861	-1,975 Reduced 15.35%	10,891 $101,000
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $28,714 - $46,279	-3,506 Reduced 21.41%	12,866 $122,000
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $37,775 - $70,317	4,938 Added 43.19%	16,372 $166,000
Q1 2022 May 12, 2022	BUY	$13.02 - $20.78 $81,257 - $129,687	6,241 Added 120.18%	11,434 $163,000
Q1 2021 May 12, 2021	BUY	$14.84 - $22.23 $77,064 - $115,440	5,193 New	5,193 $104,000

167

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $149M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.